Patent details

Basic Information

Publication number:

EP3185902

PCT Application Number:

JP2015004306

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158359364

PCT Publication Number:

WO2016031250

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD FOR TREATING PSORIASIS PATIENT WHICH RECEIVED ANTI-TNF-ALPHA ANTIBODY THERAPY

French Title of Invention:

PROCÉDÉ POUR TRAITER UN PATIENT SOUFFRANT DE PSORIASIS QUI A REÇU UN TRAITEMENT PAR ANTICORPS ANTI-TNF-ALPHA

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG EINES PSORIASISPATIENTEN, DER EINE ANTI-TNF-ALPHA-ANTIKÖRPERTHERAPIE ERHALTEN HAT

SPC Number:

Dates

Filing date:

26/08/2015

Grant date:

29/07/2020

EP Publication Date:

05/07/2017

PCT Publication Date:

03/03/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/07/2020

EP B1 Publication Date:

29/07/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/08/2020

Expiration date:

26/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/07/2020

 

 

Name:

Amgen K-A, Inc.

Address:

One Amgen Center Drive, Thousand Oaks CA 91320-1799, United States (US)

Inventor

1

Name:

NAKAGAWA, Hidemi

Address:

Japan (JP)

2

Name:

MATSUDO, Hiroki

Address:

Japan (JP)

Priority

Priority Number:

201462041862 P

Priority Date:

26/08/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; A61K 45/00; A61P 17/06; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

202031

Publication date:

29/07/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages